Inhibrx Biosciences, Inc.
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 17 | Q1 18 | Q2 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | – | 100.0% | – | 100.0% | – | – | – | – | – | |
| 2,594.0% | 431.2% | 339.8% | 206.3% | 151.7% | 1,217.4% | 63.7% | 1.5% | – | 569.1% | 340.5% | – | 1,904.8% | 1,876.5% | 26.7% | 24.4% | 76.4% | 99.6% | 258.6% | 262.8% | 1,729.4% | 983.3% | 255.5% | 18.2% | – | 475.0% | – | 689.0% | – | 50.9% | – | – | – | – | – | |
| -2,494.0% | -331.2% | -239.8% | -106.3% | 123.0% | 110.5% | 36.3% | 98.5% | 100.0% | -469.1% | -240.5% | 100.0% | -1,804.8% | 100.0% | 73.3% | 75.6% | 23.6% | 0.4% | -158.6% | -162.8% | -1,629.4% | -883.3% | -155.5% | 81.8% | – | 100.0% | – | -589.0% | – | 49.1% | – | – | – | – | – | |
| 2,594.0% | 431.2% | 339.8% | 206.3% | 151.7% | 1,217.4% | 1,610.2% | 4,600.4% | 1,951.4% | 569.1% | 340.5% | 636.5% | 1,904.8% | 1,876.5% | 730.1% | 656.4% | 2,720.8% | 4,206.2% | 8,969.1% | 11,113.5% | 218,523.5% | 112,880.0% | 31,980.7% | 5,008.5% | – | 67,632.0% | – | 33,367.0% | – | 1,712.8% | – | – | – | – | – | |
| 313.2% | 36.4% | 39.6% | 73.6% | 20.9% | 163.6% | 186.5% | 1,660.7% | 168.2% | 46.0% | 27.8% | 79.8% | 348.7% | 299.1% | 112.5% | 128.5% | 552.0% | 759.8% | 1,923.4% | 1,942.7% | 37,629.4% | 24,210.0% | 6,629.4% | 479.3% | – | 93,366.0% | – | 16,661.0% | – | 494.0% | – | – | – | – | – | |
| 313.2% | 35.3% | 39.1% | 73.0% | 20.7% | 163.2% | 633.1% | 6,262.5% | 2,119.6% | 614.9% | 367.0% | 716.2% | 346.8% | 2,175.6% | 815.8% | 760.5% | 3,196.4% | 4,866.4% | 10,633.8% | 12,793.4% | 255,817.6% | 136,913.3% | 38,354.6% | 5,485.0% | – | 160,998.0% | – | 49,339.0% | – | 2,155.9% | – | – | – | – | – | |
| -2,807.1% | -355.9% | -266.9% | -179.9% | -51.4% | -1,060.1% | -1,643.2% | -5,128.5% | -2,019.6% | -514.9% | -267.0% | -616.2% | -2,150.4% | -2,075.6% | -742.5% | -684.9% | -3,172.8% | -4,866.0% | -10,792.4% | -12,956.2% | -257,447.1% | -137,796.7% | -38,510.1% | -5,403.2% | – | -160,898.0% | – | -49,928.0% | – | -2,106.8% | – | – | – | – | – | |
| – | 18.0% | 15.5% | – | 3.5% | 49.0% | 336.3% | 865.9% | 281.1% | 102.1% | 76.0% | 19.2% | 86.3% | 95.8% | 70.2% | 62.7% | 248.5% | 442.8% | 1,920.9% | 1,950.7% | 29,882.4% | 26,350.0% | 6,847.9% | 503.2% | – | 5,361.0% | – | 0.0% | – | 241.6% | – | – | – | – | – | |
| -2,976.5% | -372.8% | -282.0% | -192.4% | -54.7% | -1,108.7% | -2,426.1% | -6,106.7% | -2,304.2% | -536.4% | -343.5% | -635.7% | -2,234.9% | -2,170.9% | -812.8% | -747.1% | -3,415.7% | -5,306.3% | -12,706.8% | -14,932.8% | -287,741.2% | -156,823.3% | -43,518.5% | -5,728.8% | – | 1,858,013.0% | – | -47,865.0% | – | -2,204.0% | – | – | – | – | – | |
| -2,976.5% | 20.6% | 20.3% | 2.0% | 3.7% | -0.2% | 113.4% | 866.3% | 282.2% | 102.0% | 8.4% | 0.1% | 0.2% | 96.3% | 70.2% | -10.8% | 244.5% | 0.6% | 1,914.4% | -0.4% | -1,323.5% | 16.7% | 1.7% | -0.2% | – | 2.0% | – | – | – | 0.2% | – | – | – | – | – | |
| -2,811.0% | -374.2% | -286.2% | -194.4% | -54.7% | -1,108.5% | -2,539.4% | -6,106.7% | -2,304.2% | -536.4% | -351.8% | -635.8% | -2,235.1% | -2,170.9% | -812.8% | -747.1% | -3,415.7% | -5,306.9% | -14,621.2% | -14,932.5% | -286,417.6% | -156,840.0% | -43,520.2% | -5,728.5% | – | 1,858,011.0% | – | -47,865.0% | – | -2,204.2% | – | – | – | – | – | |
| -2,761.9% | -348.7% | -259.8% | -171.1% | -40.3% | -436.6% | -2,024.1% | -6,186.1% | -1,989.1% | -507.6% | -267.0% | -607.0% | -2,114.8% | -2,075.1% | -730.8% | -673.4% | -3,133.7% | -4,820.4% | -10,681.3% | -12,846.0% | -241,517.6% | -129,490.0% | -36,415.1% | -5,385.0% | – | 1,863,374.0% | – | -47,176.0% | – | -1,911.5% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.